|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||268.31 - 274.31|
|52 Week Range||196.09 - 281.16|
|Beta (5Y Monthly)||0.99|
|PE Ratio (TTM)||49.20|
|Earnings Date||Oct 28, 2021|
|Forward Dividend & Yield||2.52 (0.92%)|
|Ex-Dividend Date||Sep 29, 2021|
|1y Target Est||286.83|
Subscribe to Yahoo Finance Plus to view Fair Value for SYKLearn more
Stryker's (SYK) third-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Most readers would already know that Stryker's (NYSE:SYK) stock increased by 4.9% over the past week. Given that the...